Solid lipid nanoparticles of irbesartan

Preparation, characterization, optimization and pharmacokinetic studies

Deepthi Soma, Zenab Attari, Meka Sreenivasa Reddy, Atmakuri Damodaram, Kunnatur Balasundara Gupta Koteshwara

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesartan loaded SLNs were characterized and optimized by parameters like particle size, zeta potential, surface morphology entrapment efficiency and in vitro release. The optimized formulation was then further evaluated for the pharmacokinetic studies in Wistar rats. Irbesartan-loaded SLN of particle size 523.7 nm and 73.8% entrapment efficiency showed good bioavailability in Wistar rats and also showed optimum stability in the studies. The SLN prepared using glyceryl monostearate by solvent emulsification method leads to improve bioavailability of the drug.

Original languageEnglish
Article numbere15012
JournalBrazilian Journal of Pharmaceutical Sciences
Volume53
Issue number1
DOIs
Publication statusPublished - 2017

Fingerprint

irbesartan
Nanoparticles
Biological Availability
Pharmacokinetics
Lipids
Particle Size
Wistar Rats
Sonication
Antihypertensive Agents
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{31d56e2aabe44feb8a99c1af036abce3,
title = "Solid lipid nanoparticles of irbesartan: Preparation, characterization, optimization and pharmacokinetic studies",
abstract = "Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesartan loaded SLNs were characterized and optimized by parameters like particle size, zeta potential, surface morphology entrapment efficiency and in vitro release. The optimized formulation was then further evaluated for the pharmacokinetic studies in Wistar rats. Irbesartan-loaded SLN of particle size 523.7 nm and 73.8{\%} entrapment efficiency showed good bioavailability in Wistar rats and also showed optimum stability in the studies. The SLN prepared using glyceryl monostearate by solvent emulsification method leads to improve bioavailability of the drug.",
author = "Deepthi Soma and Zenab Attari and Reddy, {Meka Sreenivasa} and Atmakuri Damodaram and Koteshwara, {Kunnatur Balasundara Gupta}",
year = "2017",
doi = "10.1590/s2175-97902017000115012",
language = "English",
volume = "53",
journal = "Brazilian Journal of Pharmaceutical Sciences",
issn = "1984-8250",
publisher = "Faculdade de Ciencias Farmaceuticas (Biblioteca-",
number = "1",

}

TY - JOUR

T1 - Solid lipid nanoparticles of irbesartan

T2 - Preparation, characterization, optimization and pharmacokinetic studies

AU - Soma, Deepthi

AU - Attari, Zenab

AU - Reddy, Meka Sreenivasa

AU - Damodaram, Atmakuri

AU - Koteshwara, Kunnatur Balasundara Gupta

PY - 2017

Y1 - 2017

N2 - Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesartan loaded SLNs were characterized and optimized by parameters like particle size, zeta potential, surface morphology entrapment efficiency and in vitro release. The optimized formulation was then further evaluated for the pharmacokinetic studies in Wistar rats. Irbesartan-loaded SLN of particle size 523.7 nm and 73.8% entrapment efficiency showed good bioavailability in Wistar rats and also showed optimum stability in the studies. The SLN prepared using glyceryl monostearate by solvent emulsification method leads to improve bioavailability of the drug.

AB - Irbesartan is an antihypertensive with limited bioavailability and solid lipid nanoparticles (SLN) is one of the approaches to improve bioavailability. Solid lipid nanoparticles were prepared using glyceryl monostearate by solvent emulsification method followed by probe sonication. Irbesartan loaded SLNs were characterized and optimized by parameters like particle size, zeta potential, surface morphology entrapment efficiency and in vitro release. The optimized formulation was then further evaluated for the pharmacokinetic studies in Wistar rats. Irbesartan-loaded SLN of particle size 523.7 nm and 73.8% entrapment efficiency showed good bioavailability in Wistar rats and also showed optimum stability in the studies. The SLN prepared using glyceryl monostearate by solvent emulsification method leads to improve bioavailability of the drug.

UR - http://www.scopus.com/inward/record.url?scp=85018713579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018713579&partnerID=8YFLogxK

U2 - 10.1590/s2175-97902017000115012

DO - 10.1590/s2175-97902017000115012

M3 - Article

VL - 53

JO - Brazilian Journal of Pharmaceutical Sciences

JF - Brazilian Journal of Pharmaceutical Sciences

SN - 1984-8250

IS - 1

M1 - e15012

ER -